Testing effectiveness (Phase 2)Study completedNCT01265498
What this trial is testing
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 283